The abstract is read at the publisher; the summary is JClub's.
An implementation framework for difficult-to-manage and complex-to-manage psoriatic arthritis proposes dual-denominator prevalence reporting and mechanism-aware phenotypes to improve reproducibility.
- Why it matters: Prevalence estimates are hard to interpret because studies use different denominators, define treatment failure differently, and struggle to separate persistent symptoms from objective inflammation.
- What they did: The Viewpoint builds on EULAR difficult-to-manage and GRAPPA complex-to-manage definitions, recommending dual-denominator reporting and an auditable treatment ledger capturing drug mechanism, exposure adequacy, optimisation attempts, and discontinuation reasons.
- The result: After pathway difficulty is established, patients should be stratified by dominant drivers of persistent burden—non-inflammatory, inflammatory, or mixed—using domain-specific profiling, disease duration, and prespecified sensitivity analyses to improve comparability across registries, trials, and translational studies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.